ODTXOdyssey Therapeutics Inc. Common Stock
26.39USD+6.97%Mkt Cap: 1.27B $P/E: —3d ago
Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company pipeline includes OD-001, an oral small molecule inhibitor of receptor-inte…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap1.27B $
Enterprise Value896.40M $
Revenue (TTM)99.00K $
Gross Profit-120.62M $
Net Income (TTM)-148.65M $
Revenue/Share0.0090 USD
Last Price26.39 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees100
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-5.66
PEG—
EV/EBITDA-5.96
EV/Revenue9054.53
P/S11975.80
P/B2.81
EPS (TTM)-3.40
EPS (Forward)-4.36
52W Range
15.1099% of range26.49
52W High26.49 USD
52W Low15.10 USD
Profitability
Gross Margin0.00%
Oper. Margin-156392.92%
EBITDA Margin0.00%
Profit Margin-4994.86%
ROE30.44%
ROA-55.10%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-129.47M $
CapEx (TTM)1.23M $
FCF Margin—
FCF Yield—
Net Debt-285.75M $
Net Debt/EBITDA1.90
Balance Sheet
Debt/Equity-0.06
Current Ratio11.36
Quick Ratio10.98
Book Value/Sh8.795 USD
Cash/Share6.481 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)33.00 USD
Upside (mean)+25.0%
Target Range29.00 USD – 40.00 USD
$29.00+25.0% to mean$40.00
# Analysts3
Ownership
Shares Out.48.06M
Float19.97M
Insiders6.07%
Institutions82.91%
Short Interest
Short Ratio8.1d
Short % Float5.40%
Short % Out.4.73%
Shares Short2.27M
Short (prev mo.)1.80M
Technical
SMA 5018.73 (+40.9%)
SMA 20018.27 (+44.4%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)205.83K
Avg Vol (10d)134.21K
Technical Indicators
RSI (14)75.2
MACD1.6222
MACD Signal1.1305
MACD Hist.+0.4917
BB Upper25.41 USD
BB Middle20.91 USD
BB Lower16.42 USD
BB Width42.98%
ATR (14)1.673 USD
Vol Ratio (20d)1.31x